Abstract
Vasovagal syncope (VVS) is a non-life-threatening disorder, and in most patients pharmacological treatment is not required. However, patients with recurrent episodes of syncope, and especially those suffering from prior injuries, are likely to have impaired quality of life. Drug therapies are appropriate for these patients. Despite numerous efforts and trials, therapeutic options in patients with VVS are very limited; there are no pharmacological treatments that have convincingly been shown to be effective in large clinical trials.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Von Scheidt W, Bosch R, Klingenheben T, Schuchert A, Stellbrink C, Stockburger M. Commentary on the 2018 ESC Guidelines for the diagnosis and management of syncope. Kardiologe. 2019;13(3):131–7. https://doi.org/10.1007/s12181-019-0317-2.
Sahota I, Sheldon R, Pournazari P. Clinical improvement of vasovagal syncope in the absence of specific therapies: the Seinfeld effect. Cardiol J. 2014;21(6):637–42. https://doi.org/10.5603/CJ.2014.0096.
Sheldon RS, Grubb BP, Olshansky B, et al. 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural Tachycardia Syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Hear Rhythm. 2015;12(6):e41–63. https://doi.org/10.1016/j.hrthm.2015.03.029.
Shen W-K, Sheldon R, Benditt DG, et al. Correction to: 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients with Syncope: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society. Circulation. 2017;136(5):e60–e122. https://doi.org/10.1161/CIR.0000000000000537.
Solari D, Tesi F, Unterhuber M, et al. Stop vasodepressor drugs in reflex syncope: a randomised controlled trial. Heart. 2017;103(6):449–55. https://doi.org/10.1136/heartjnl-2016-309865.
Wiersum-Osselton J, Romeijn B, Van den Brekel E, et al. Can we prevent vasovagal reactions in young inexperienced whole blood donors? A placebo controlled study comparing effects of a 330 vs 500 mL water drink prior to donation. Transfusion. 2019;59(2):555–65. https://doi.org/10.1111/trf.15065.
Chu W, Wang C, Wu L, Lin P, Li F, Zou R. Oral rehydration salts: an effective choice for the treatment of children with Vasovagal syncope. Pediatr Cardiol. 2015;36(4):867–72. https://doi.org/10.1007/s00246-015-1097-5.
Pournazari P, Sahota I, Sheldon R. High remission rates in Vasovagal syncope: systematic review and meta-analysis of observational and randomized studies. JACC Clin Electrophysiol. 2017;3(4):384–92. https://doi.org/10.1016/j.jacep.2016.10.012.
van Dijk N, Quartieri F, Blanc JJ, et al. Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope. The physical counterpressure manoeuvers trial (PC-Trial). J Am Coll Cardiol. 2006;48(8):1652–7. https://doi.org/10.1016/j.jacc.2006.06.059.
Tomaino M, Romeo C, Vitale E, et al. Physical counter-pressure manoeuvers in preventing syncopal recurrence in patients older than 40 years with recurrent neurally mediated syncope: A controlled study from the Third International Study on Syncope of Uncertain Etiology (ISSUE-3). Europace. 2014;16(10):1515–20. https://doi.org/10.1093/europace/euu125.
Coffin ST, Raj SR. Non-invasive management of vasovagal syncope. Auton Neurosci Basic Clin. 2014;184:27–32. https://doi.org/10.1016/j.autneu.2014.06.004.
Romme JJCM, Reitsma JB, Black CN, et al. Drugs and pacemakers for vasovagal, carotid sinus and situational syncope. Cochrane Database Syst Rev. 2011;2011(10):CD004194. https://doi.org/10.1002/14651858.CD004194.pub3.
Romme JJCM, Van Dijk N, Go-Schön IK, Reitsma JB, Wieling W. Effectiveness of Midodrine treatment in patients with recurrent vasovagal syncope not responding to non-pharmacological treatment (STAND-trial). Europace. 2011;13(11):1639–47. https://doi.org/10.1093/europace/eur200.
Izcovich A, Malla CG, Manzotti M, Catalano HN, Guyatt G. Midodrine for orthostatic hypotension and recurrent reflex syncope: a systematic review. Neurology. 2014;83(13):1170–7. https://doi.org/10.1212/WNL.0000000000000815.
Raj SR, Faris PD, McRae M, Sheldon RS. Rationale for the prevention of syncope trial IV: assessment of midodrine. Clin Auton Res. 2012;22(6):275–80. https://doi.org/10.1007/s10286-012-0167-5.
Sheldon R, Raj SR, Rose MS, et al. Fludrocortisone for the prevention of vasovagal syncope a randomized, placebo-controlled trial. J Am Coll Cardiol. 2016;68(1):1–9. https://doi.org/10.1016/j.jacc.2016.04.030.
Brignole M, Guieu R, Tomaino M, et al. Mechanism of syncope without prodromes with normal heart and normal electrocardiogram. Hear Rhythm. 2017;14(2):234–9. https://doi.org/10.1016/j.hrthm.2016.08.046.
Schroeder C, Birkenfeld AL, Mayer AF, et al. Norepinephrine transporter inhibition prevents tilt-induced pre-syncope. J Am Coll Cardiol. 2006;48(3):516–22. https://doi.org/10.1016/j.jacc.2006.04.073.
Sheldon RS, Ritchie D, McRae M, Raj S. Norepinephrine transport inhibition for treatment of vasovagal syncope. J Cardiovasc Electrophysiol. 2013;24(7):799–803. https://doi.org/10.1111/jce.12111.
Sheldon RS, Lei L, Guzman JC, et al. A proof of principle study of atomoxetine for the prevention of vasovagal syncope: the Prevention of Syncope Trial VI. Europace. 2019;21(11):1733–41. https://doi.org/10.1093/europace/euz250.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Pournazari, P., Raj, S.R. (2020). Non-Pharmacological and Pharmacological Therapies in Vasovagal Syncope: Current Status. In: Brignole, M., Benditt, D. (eds) Syncope. Springer, Cham. https://doi.org/10.1007/978-3-030-44507-2_23
Download citation
DOI: https://doi.org/10.1007/978-3-030-44507-2_23
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-44506-5
Online ISBN: 978-3-030-44507-2
eBook Packages: MedicineMedicine (R0)